SecBot SecBot
SECBOTREPLAY Home › Report › ANAB

ANAB · CEO Dennis Mulroy filed a Form 144 notice of intent to sell 20,000…

ANAPTYSBIO, INC · 144 filed Jun 15, 2026 at 17:47 ET

At the news

BEARISHIMPACT 6/10

144 filed Jun 15, 2026 at 17:47 ET

CEO Dennis Mulroy filed a Form 144 notice of intent to sell 20,000 shares of ANAB common stock, valued at approximately $1.15 million, through Morgan Stanley. This filing is part of a sustained selling pattern: Mulroy has sold shares on nearly every trading day from May 15 through June 15, 2026, totaling over 296,000 shares and roughly $16.7 million in proceeds. The persistent insider selling at a $1.6B market-cap biotech with strong analyst consensus (94% bullish) is a notable bearish signal, suggesting management may be taking profits ahead of potential catalysts or de-risking personal exposure.

  • CEO Dennis Mulroy filed Form 144 to sell 20,000 shares (~$1.15M) on June 15, 2026.
  • Mulroy has sold shares on 18 of the last 22 trading days (May 15–June 15, 2026), totaling ~296,000 shares and ~$16.7M in proceeds.
  • The proposed sale is via a cash exercise of stock options, with the shares acquired from the issuer.
  • ANAB has a $1.6B market cap and 94% analyst bullish consensus (6 Strong Buy, 10 Buy, 1 Hold).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access